.jpg)
Pathogenetic Therapy of Patients with Chronic Bacterial Prostatitis
The antibacterial therapy of chronic bacterial prostatitis in use does not always lead to the disappearance of clinical symptoms, does not prevent recurrences and is not always efficient concerning inflammation agent due to the peculiarities of prostate blood supply. At the same time, healthy prostatic fluid is able to suppress the generation of the majority of pathogenic bacteria including clamydia.
The aim of the study is to clarify the role of prostate functional recovery in treating chronic bacterial prostatitis (class II) and achieving a long-term therapeutic effect.
Materials and Methods. There were examined 1106 males, aged 24—52, with clinical presentation of chronic prostatitis, and in 345 of them (31.2%) a bacterial component of the inflammation was confirmed by laboratory findings. The patients were divided into two groups.
Results. The treatment results of 2 groups were compared. 1st group patients (n=189) were treated using a traditional approach and in the 2nd group (n=156) the therapy objective was to recover prostate functional capabilities without antibiotics administration despite of the presence of leukocytes in prostate exprimate and bacterial culture. The comparison showed a positive effect of prostate trophism recovery on the course of an inflammatory process. The inflammatory process in prostate (clinical symptoms disappearance, the reduction of white blood count in prostatic fluid) was stated to stop despite of the presence of microflora revealed in bacterial inoculation.
